KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$1.1 million.

  • Fulgent Genetics' Change in Accured Expenses rose 3804.05% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year decrease of 14782.83%. This contributed to the annual value of -$4.0 million for FY2024, which is 24573.22% down from last year.
  • Per Fulgent Genetics' latest filing, its Change in Accured Expenses stood at -$1.1 million for Q3 2025, which was up 3804.05% from $5.2 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Change in Accured Expenses peaked at $20.0 million during Q2 2021, and registered a low of -$13.2 million during Q3 2022.
  • Moreover, its 5-year median value for Change in Accured Expenses was -$177000.0 (2023), whereas its average is -$131105.3.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 487935.32% in 2021, then tumbled by 93220.34% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Change in Accured Expenses stood at -$8.2 million in 2021, then soared by 124.35% to $2.0 million in 2022, then soared by 423.32% to $10.4 million in 2023, then plummeted by 93.97% to $628000.0 in 2024, then plummeted by 280.25% to -$1.1 million in 2025.
  • Its Change in Accured Expenses stands at -$1.1 million for Q3 2025, versus $5.2 million for Q2 2025 and -$7.5 million for Q1 2025.